Patel Sujal M

CEO Sujal M Patel buys 25,000 NAUT shares at $2.61; mixed track record at this ticker.

CEO Sujal M Patel purchased 25,000 shares at $2.61, increasing holdings from 10,341,721 to 10,366,721 shares. His prior trades at NAUT show highly inconsistent outcomes: two September 2025 buys generated 90-day returns of +197.2% and +207.0%, but two March 2025 buys delivered -29.1% and -29.6%, with only 2 of 5 prior buys at this ticker proving well-timed at the 90-day mark. The company remains unprofitable with net income of $-13.6M over its most recent fiscal year. The stock is trading at $2.62, down 9.3% from its 52-week high of $2.89, though up 30.4% over the past 30 days and 26.6% over 90 days, placing this buy during a period of recent strength rather than a depressed entry point. The bifurcated timing history at NAUT—spectacular wins paired with significant losses—makes this purchase difficult to characterize as driven by consistent conviction.

CEO Sujal M Patel buys 200,000 shares at blended $0.68 after stock falls 78.2% from 52-week high.

Patel Sujal M executed 2 separate open-market purchases totaling 200,000 shares for $135,574.80 on 2025-09-05 and 2025-09-08, increasing his holdings by 2.0% to 10,341,721 shares. The timing is notable: the stock trades at $0.67 current price, down 78.2% from the 52-week high of $3.08 and down 8.3% over the prior 30 days. However, Patel's prior trades at NAUT show a consistent pattern of poor timing—0 of 5 prior buys achieved positive 90-day returns, with most recent March 2025 purchases showing -24.1% and -23.8% 30-day losses respectively. The company's fundamentals remain challenging, posting a net loss of $15,033,000 on a market cap of $84,624,431.74, providing limited context for why accumulated holdings now exceed 10.3M shares at severely depressed valuations.

CEO Sujal M Patel buys 77,233 shares (77.2K) at blended $1.00; stock down 67.9% from 52-week high; unprofitable company.

CEO Sujal M Patel executed 2 separate purchases totaling 77,233 shares for $76,918.09 on 2025-03-19 and 2025-03-20, acquiring shares at $0.99 and $1.00 respectively. At current price of $0.99, the stock is down 67.9% from its 52-week high of $3.08 and has fallen 40.7% over the past 30 days and 43.8% over 90 days. His prior trade history at NAUT shows 5 preceding buys, of which only 1 (20% win rate) achieved positive 90-day returns; the remaining four buys resulted in declines ranging from 0.2% to 10.7% over 90 days. Nautilus Biotechnology reported negative net income of $16,446,000 over its most recent full fiscal year, indicating ongoing unprofitability despite the CEO's accumulation activity.